Design and rationale for RE-VERSE AD: a phase 3 study of idarucizumab, a specific reversal agent for dabigatran
by Pollack, Charles V. (Author)
, Reilly, Paul A. (Author)
, Bernstein, Richard (Author)
, Dubiel, Robert (Author)
, Eikelboom, John (Author)
, Glund, Stephan (Author)
, Huisman, Menno V. (Author)
, Hylek, Elaine (Author)
, Kam, Chak-Wah (Author)
, Kamphuisen, Pieter W. (Author)
, Kreuzer, Joerg (Author)
, Levy, Jerrold H. (Author)
, Sellke, Frank (Author)
, Stangier, Joachim (Author)
, Steiner, Thorsten (Author)
, Wang, Bushi (Author)
, Weitz, Jeffrey I. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource